Stephen C. Glover - May 24, 2023 Form 4 Insider Report for ZyVersa Therapeutics, Inc. (ZVSA)

Role: Chief Executive Officer, Director
Signature: /s/ Peter Wolfe as Attorney-in-Fact for Stephen C. Glover pursuant to Power of Attorney
Stock symbol: ZVSA
Transactions as of: May 24, 2023
Transactions value $: $0
Form type: 4
Date filed: 7/18/2024, 09:35 PM
Previous filing: May 19, 2023
Next filing: Jul 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZVSA	Stock Options	Award	$0	+1.63K		$0.00	1.63K	May 24, 2023	Common Stock	1.63K	$152.46	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option disclosed on this Form 4 was not previously reported due to an administrative oversight.
F2	Share and dollar amounts give effect to the issuer's 1-for-35 reverse stock split effectuated on December 4, 2023, and 1-for-10 reverse stock split effectuated on April 25, 2024.
F3	The option vests annually in three equal installments commencing on May 24, 2024.

Remarks:

Exhibit 24.1 - Power of Attorney